Kim Blom

1.8k total citations
31 papers, 786 citations indexed

About

Kim Blom is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Kim Blom has authored 31 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 11 papers in Public Health, Environmental and Occupational Health and 8 papers in Immunology. Recurrent topics in Kim Blom's work include Mosquito-borne diseases and control (11 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Viral Infections and Vectors (10 papers). Kim Blom is often cited by papers focused on Mosquito-borne diseases and control (11 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Viral Infections and Vectors (10 papers). Kim Blom collaborates with scholars based in Sweden, United States and Lithuania. Kim Blom's co-authors include Johan K. Sandberg, Karolin Falconer, Hans‐Gustaf Ljunggren, Annette Alaeus, Jakob Michaëlsson, Verónica González, Veronica D. Gonzalez, Monika Braun, Niklas K. Björkström and Jonas Klingström and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Kim Blom

29 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kim Blom Sweden	14	372	314	194	140	129	31	786
Yean K. Yong Malaysia	19	426 1.1×	503 1.6×	225 1.2×	354 2.5×	156 1.2×	49	1.2k
Luke S. Uebelhoer United States	12	512 1.4×	203 0.6×	78 0.4×	223 1.6×	104 0.8×	19	824
Simona Ruţă Romania	16	382 1.0×	59 0.2×	168 0.9×	298 2.1×	110 0.9×	86	782
Helene Paxton United States	18	404 1.1×	143 0.5×	152 0.8×	129 0.9×	211 1.6×	25	800
David J. C. Miles United Kingdom	20	253 0.7×	384 1.2×	117 0.6×	402 2.9×	99 0.8×	32	1.0k
Mariane M. A. Stefani Brazil	21	799 2.1×	116 0.4×	101 0.5×	620 4.4×	118 0.9×	53	1.1k
M J McElrath United States	12	291 0.8×	381 1.2×	319 1.6×	375 2.7×	528 4.1×	13	960
Kevin T. Stephan United States	10	451 1.2×	409 1.3×	148 0.8×	175 1.3×	658 5.1×	14	1.0k
Jin Leng United States	10	215 0.6×	403 1.3×	68 0.4×	151 1.1×	323 2.5×	15	822
José M. Miró Spain	17	634 1.7×	271 0.9×	45 0.2×	206 1.5×	763 5.9×	37	1.0k

Countries citing papers authored by Kim Blom

Since Specialization

Citations

This map shows the geographic impact of Kim Blom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Blom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Blom more than expected).

Fields of papers citing papers by Kim Blom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Blom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Blom. The network helps show where Kim Blom may publish in the future.

Co-authorship network of co-authors of Kim Blom

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Blom. A scholar is included among the top collaborators of Kim Blom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Blom. Kim Blom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blom, Kim, Ilias Galanis, Klara Sondén, et al.. (2025). High prevalence of undocumented SARS-CoV-2 infections revealed by analysis of nucleocapsid-specific IgG responses in diagnosed and undiagnosed individuals. PLOS Global Public Health. 5(1). e0003300–e0003300. 1 indexed citations

Pettersson, John H.‐O., Johan Aarum, Oskar Karlsson Lindsjö, et al.. (2025). Qdenga-induced dengue caused by minor DENV-2 subvariant(s) in the vaccine, with two amino acid substitutions in the E protein. Journal of Travel Medicine. 32(7).

Marking, Ulrika, Katherina Aguilera, Tamás Pongrácz, et al.. (2025). Impact of systemic SARS-CoV-2 vaccination on mucosal IgA responses to subsequent breakthrough infection. EBioMedicine. 120. 105912–105912. 1 indexed citations

Wullimann, David, John Tyler Sandberg, Mira Akber, et al.. (2025). Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort. PLoS neglected tropical diseases. 19(2). e0012693–e0012693. 3 indexed citations

Mold, Jeff E., Michael Ratz, Michael Hagemann-Jensen, et al.. (2024). Clonally heritable gene expression imparts a layer of diversity within cell types. Cell Systems. 15(2). 149–165.e10. 15 indexed citations

Aguilera, Katherina, Ulrika Marking, Nina Greilert‐Norin, et al.. (2024). Prevalence of SARS-CoV-2 infections among Swedish healthcare workers on duty in December 2023. The Lancet Regional Health - Europe. 38. 100872–100872.

Aguilera, Katherina, Ulrika Marking, Nina Greilert‐Norin, et al.. (2024). Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum. Frontiers in Immunology. 15. 1346749–1346749. 11 indexed citations

Blom, Kim, Sebastian Havervall, Ulrika Marking, et al.. (2023). Point prevalence of SARS-CoV-2 infection among healthcare workers in March and June 2023 in Sweden. The Lancet Regional Health - Europe. 33. 100725–100725. 2 indexed citations

Marking, Ulrika, Sebastian Havervall, Nina Greilert‐Norin, et al.. (2023). Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers. Nature Communications. 14(1). 1577–1577. 12 indexed citations

10.

Sandberg, John Tyler, Renata Varnaitė, Johanna Emgård, et al.. (2023). Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial. PLoS neglected tropical diseases. 17(2). e0010616–e0010616. 6 indexed citations

11.

Groenheit, Ramona, Ilias Galanis, Klara Sondén, et al.. (2023). High Prevalence of SARS-CoV-2 Omicron Infection Despite High Seroprevalence, Sweden, 2022. Emerging infectious diseases. 29(6). 1240–1243. 5 indexed citations

12.

Groenheit, Ramona, Ilias Galanis, Klara Sondén, et al.. (2022). Rapid emergence of omicron sublineages expressing spike protein R346T. The Lancet Regional Health - Europe. 24. 100564–100564. 12 indexed citations

13.

Havervall, Sebastian, Ulrika Marking, Nina Greilert‐Norin, et al.. (2022). Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time. Clinical & Translational Immunology. 11(4). e1388–e1388. 13 indexed citations

14.

Varnaitė, Renata, Marina García, Hedvig Glans, et al.. (2020). Expansion of SARS-CoV-2–Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients. The Journal of Immunology. 205(9). 2437–2446. 56 indexed citations

15.

Varnaitė, Renata, Kim Blom, Margit H. Lampen, et al.. (2020). Magnitude and Functional Profile of the Human CD4+ T Cell Response throughout Primary Immunization with Tick-Borne Encephalitis Virus Vaccine. The Journal of Immunology. 204(4). 914–922. 11 indexed citations

16.

Blom, Kim, Li Yin, & Lisen Arnheim‐Dahlström. (2019). Effectiveness of the herpes zoster vaccine Zostavax® in Stockholm County, Sweden. Vaccine. 37(31). 4401–4406. 10 indexed citations

17.

Lampen, Margit H., Hannes Uchtenhagen, Kim Blom, et al.. (2018). Breadth and Dynamics of HLA-A2– and HLA-B7–Restricted CD8+ T Cell Responses against Nonstructural Viral Proteins in Acute Human Tick-Borne Encephalitis Virus Infection. ImmunoHorizons. 2(6). 172–184. 13 indexed citations

18.

Flach, Britta, Prossy Naluyima, Kim Blom, et al.. (2013). Differential Loss of Invariant Natural Killer T Cells and FoxP3+ Regulatory T Cells in HIV-1 Subtype A and Subtype D Infections. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(3). 289–293. 4 indexed citations

19.

Blom, Kim, Monika Braun, Martin A. Ivarsson, et al.. (2013). Temporal Dynamics of the Primary Human T Cell Response to Yellow Fever Virus 17D As It Matures from an Effector- to a Memory-Type Response. The Journal of Immunology. 190(5). 2150–2158. 76 indexed citations

20.

González, Verónica, Karolin Falconer, Kim Blom, et al.. (2009). High Levels of Chronic Immune Activation in the T-Cell Compartments of Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus Type 1 and on Highly Active Antiretroviral Therapy Are Reverted by Alpha Interferon and Ribavirin Treatment. Journal of Virology. 83(21). 11407–11411. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact